Prognostic implication of CEACAM1 expression in squamous cell carcinoma of the larynx: pilot study

G Lucarini, A Zizzi, M Re, MA Sayeed… - Head & …, 2019 - Wiley Online Library
Background CEACAM1, a valuable biomarker for several cancers, have remained
unexplored up to the present in laryngeal squamous cell carcinoma (LSCC). We aimed to …

Y‐Chromosome‐Linked Genes Are Associated With Sex‐Related Head‐Neck Squamous Cell Carcinoma Survival

X Feng, T Zhang, J Chou, HS Patwa… - … –Head and Neck …, 2023 - Wiley Online Library
Objective To define novel gene biomarkers for prognosis of head and neck squamous cell
carcinoma (HNSCC) patients' survival. Study Design Retrospective study. Setting The …

Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response …

M van Duijvenvoorde, S Derks, I Bahce… - Clinical & …, 2022 - Wiley Online Library
Immunotherapy with immune checkpoint inhibitors (ICI) has improved treatment outcomes in
many cancer types and has focused attention on cancer immunity and the role of the tumor …

Adenosine-mediated immunosuppression in patients with squamous cell carcinoma of the head and neck

M Mandapathil - Hno, 2016 - Springer
This review article describes the potential role of ectonucleotidase activity, adenosine
metabolism, and the adenosinergic signaling pathway in the suppression of the host …

[HTML][HTML] Identification and validation of potential long non‑coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma

J Li, Y Li, X Wu, Y Li - Oncology Letters, 2019 - spandidos-publications.com
Long non‑coding RNAs (lncRNAs) are frequently dysregulated in cancer and their aberrant
expression has been associated with cancer diagnosis and prognosis, which suggests that …

Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation

DW Bowles, JD McDermott, A Jimeno - Future Oncology, 2014 - Future Medicine
Head and neck squamous cell carcinoma (HNSCC) is a common cancer worldwide.
Classically, it is a disease related to tobacco and alcohol use; an increasing number of …

[HTML][HTML] 头颈部不同部位肿瘤动物模型的建立及生长转移特性比较

李文晋, 牛金亮, 朱莉, 王涛, 王瑜, 余佳丽 - 中国组织工程研究, 2016 - cjter.com
头颈部不同部位肿瘤动物模型的建立及生长转移特性比较 中国组织工程研究 首页 关于本刊 编委
会 在线投稿 期刊公告 出版道德 OA政策 作者学院 在线问答 联系我们 English 中国组织工程研究 …

Immunotherapy in head and neck cancer: Harnessing profit on a system disruption

C Rancoule, A Vallard, S Espenel, JB Guy, Y Xia… - Oral Oncology, 2016 - Elsevier
Immune system deregulation and evasion play a key role in cancers' evolution and
progression, including squamous cell carcinoma of the head and neck (SCCHN) …

Recent Advances in Head and Neck Tumor Microenvironment–Based Therapy

MA Macha, NA Wani, RA Ganai, AA Bhat… - … Brain to the Skin–Part B, 2020 - Springer
Head and neck squamous cell carcinomas (HNSCCs) are a group of heterogeneous
aggressive tumors affecting more than half a million patients worldwide annually. While the …

Oral sampling methods are associated with differences in immune marker concentrations

C Fakhry, F Qeadan, RH Gilman, P Yori… - The …, 2018 - Wiley Online Library
Objective To determine whether the concentration and distribution of immune markers in
paired oral samples were similar. Study Type Clinical research. Study Design Cross …